ArticleAnnals of the rheumatic diseases2021

Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini

Sara Monti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.